Legal Representation
Attorney
Louis K Ebling
USPTO Deadlines
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 11, 2005 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jul 11, 2005 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Dec 11, 2004 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Dec 11, 2004 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Dec 11, 2004 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| May 6, 2004 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Apr 14, 2004 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 14, 2004 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 23, 2004 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Dec 30, 2003 | CFIT | O | CASE FILE IN TICRS | Loading... |
| Dec 11, 2003 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 11, 2003 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 13, 2003 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Nov 12, 2002 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Oct 28, 2002 | CNSI | S | INQUIRY AS TO SUSPENSION MAILED | Loading... |
| Oct 15, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 5, 2002 | CNSL | S | LETTER OF SUSPENSION MAILED | Loading... |
| Jan 16, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 16, 2001 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Jul 12, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 001
Bioassay system containing four phenotypes-dopaminergic, GABAergic, serotonergic and cholinergic neurons, used to determine whether small molecules, proteins, and/or conditioned media from cells selectively prevent death of nerve cells
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Bioassay services, namely, services to detect specific neurotrophic factors in clinical research
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
042